Top compounds associated with response to LUZP2


Feature Type Standardized
Nominal ANOVA
mRNA GSK-1904529A GDSC1000 pan-cancer AAC -0.081 0.02
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC 0.17 0.02
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.079 0.02
mRNA bid1870 gCSI pan-cancer AAC -0.13 0.02
mRNA LFM-A13 GDSC1000 pan-cancer AAC -0.082 0.02
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.084 0.02
mRNA ABT-263 FIMM pan-cancer AAC -0.33 0.02
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.076 0.02
mRNA AP-24534 FIMM pan-cancer AAC -0.38 0.02
mRNA shikonin GDSC1000 pan-cancer AAC -0.077 0.03
Download CSV